Associated conflicts of interest among systematic review authors of long acting reversible contraceptives and the nature of the results and conclusions of these reviews
- Conditions
- FCOI IN LARC
- Registration Number
- JPRN-UMIN000039680
- Lead Sponsor
- Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Not provided
Furthermore, studies will be included which compare 1) LARCs to each other, 2) LARCs to oral contraceptives or 3) LARCs to nonpharmacologic therapy or placebo. Studies must have outcomes for one or more of the following 1) efficacy, 2) side effects including pain, nausea, weight gain, obesity, or preeclampsia etc 4) adverse events including complications, expulsion, perforation, infection, anemia, and/or bleeding, 5) application/insertion, or 6) promotion of use. Furthermore, to qualify for inclusion, systematic reviews must have been published from September of 2016 through January of 2020. Only systematic reviews published in English and reviews that synthesize studies of human or animal data will be included. Published poster presentations and conference abstracts will be excluded.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thus, the purpose of this study is to evaluate potential conflicts of interest of reviewers in systematic reviews focused on long acting reversible contraceptives.
- Secondary Outcome Measures
Name Time Method